Akzo Nobel India Limited (IN:AKZOINDIA)
:AKZOINDIA
Want to see IN:AKZOINDIA full AI Analyst Report?
Top Page
Akzo Nobel India Limited
(AKZOINDIA)
Select Model
Select Model
Rating:69Neutral
Price Target:
₹3,232.00
▲(1.58% Upside)
Action:ReiteratedDate:10/24/25
Akzo Nobel India Limited's strong financial performance is the primary driver of its stock score, supported by robust revenue growth and profitability. However, technical indicators suggest a cautious outlook with potential short-term bearish sentiment. The valuation indicates a relatively high P/E ratio, which may deter value-focused investors, although the dividend yield offers some appeal.
Positive Factors
Balance-sheet strength
Extremely low leverage and a high ROE provide durable financial flexibility. With Debt/Equity at 0.05 and a strong equity ratio, the company can self-finance capex, weather cyclical downturns, maintain dividends and fund strategic initiatives without material refinancing risk.
Negative Factors
Recent revenue contraction
A nearly 7% recent revenue decline is a structural warning sign if it persists. Falling top-line reduces operating leverage benefits, can erode market position versus peers, and limits the firm's ability to fund long-term initiatives without margin or cost offsetting actions.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance-sheet strength
Extremely low leverage and a high ROE provide durable financial flexibility. With Debt/Equity at 0.05 and a strong equity ratio, the company can self-finance capex, weather cyclical downturns, maintain dividends and fund strategic initiatives without material refinancing risk.
Read all positive factors
Akzo Nobel India Limited (AKZOINDIA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹134.35B
Dividend Yield3.04%
Average Volume (3M)825.00
Price to Earnings (P/E)48.7
Beta (1Y)0.42
Revenue Growth-6.99%
EPS Growth355.21%
CountryIN
Employees1,500
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)16.32
Shares Outstanding45,540,314
10 Day Avg. Volume793
30 Day Avg. Volume825
Financial Highlights & Ratios
PEG Ratio55.67
Price to Book (P/B)12.09
Price to Sales (P/S)3.96
P/FCF Ratio78.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)97.3
Revenue Forecast (FY)₹39.88B
Akzo Nobel India Limited Business Overview & Revenue Model
Company Description
Akzo Nobel India Limited manufactures, distributes, and sells paints and coatings in India and internationally. It offers marine and protective, powder, industrial, and automotive and specialty coatings; paints, varnishes, enamels, lacquers, and e...
How the Company Makes Money
Akzo Nobel India primarily makes money by selling paints and coatings in India. Its revenue model is largely product-sales driven across two main streams: (1) Decorative paints (consumer-facing): earnings come from the sale of interior and exterio...
Akzo Nobel India Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
72
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.76B | 40.65B | 39.37B | 37.77B | 31.09B | 23.97B |
| Gross Profit | 13.92B | 16.04B | 15.69B | 14.83B | 12.26B | 9.88B |
| EBITDA | 24.70B | 6.68B | 6.66B | 5.49B | 4.54B | 3.64B |
| Net Income | 19.91B | 4.29B | 4.27B | 3.35B | 2.90B | 2.08B |
Balance Sheet | ||||||
| Total Assets | 36.51B | 29.03B | 29.04B | 27.41B | 25.92B | 25.30B |
| Cash, Cash Equivalents and Short-Term Investments | 2.83B | 2.87B | 5.14B | 5.53B | 4.47B | 7.19B |
| Total Debt | 1.25B | 621.00M | 604.00M | 697.00M | 705.00M | 787.00M |
| Total Liabilities | 13.95B | 15.73B | 15.74B | 14.24B | 13.32B | 12.42B |
| Stockholders Equity | 22.55B | 13.30B | 13.30B | 13.16B | 12.60B | 12.88B |
Cash Flow | ||||||
| Free Cash Flow | -2.19B | 2.04B | 3.67B | 3.82B | 580.00M | 2.55B |
| Operating Cash Flow | -1.95B | 3.11B | 4.86B | 4.86B | 1.21B | 2.83B |
| Investing Cash Flow | 10.57B | 1.23B | -860.00M | -151.00M | 2.30B | -2.25B |
| Financing Cash Flow | -8.60B | -4.59B | -4.39B | -3.02B | -3.46B | -1.74B |
Akzo Nobel India Limited Technical Analysis
Negative
3181.65
Price Trends
2936.05
Negative
3084.77
Negative
3235.16
Negative
Market Momentum
12.80
Negative
48.88
Neutral
47.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:AKZOINDIA, the sentiment is Negative. The current price of 3181.65 is above the 20-day moving average (MA) of 2925.81, above the 50-day MA of 2936.05, and below the 200-day MA of 3235.16, indicating a neutral trend. The MACD of 12.80 indicates Negative momentum. The RSI at 48.88 is Neutral, neither overbought nor oversold. The STOCH value of 47.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:AKZOINDIA.
Akzo Nobel India Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹198.93B | 28.50 | ― | 0.39% | -3.66% | -1.60% | |
69 Neutral | ₹134.35B | 48.69 | ― | 3.04% | -6.99% | 355.21% | |
65 Neutral | ₹40.98B | 37.48 | ― | 0.30% | 2.19% | 4.12% | |
64 Neutral | ₹24.09B | 45.97 | ― | 0.30% | 29.19% | 27.65% | |
64 Neutral | ₹159.39B | 39.21 | ― | 1.11% | 1.79% | -49.10% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
IN:AKZOINDIA
Akzo Nobel India Limited
2,950.20
-338.41
-10.29%
IN:GPIL
Godawari Power & Ispat Ltd.
296.30
114.89
63.33%
IN:INDIGOPNTS
Indigo Paints Ltd
859.50
-127.91
-12.95%
IN:KANSAINER
Kansai Nerolac Paints Limited
197.10
-53.47
-21.34%
IN:ORIENTTECH
Orient Technologies Limited
273.50
-34.82
-11.29%
IN:SIRCA
Sirca Paints India Ltd.
424.10
141.02
49.82%
Akzo Nobel India Limited Corporate Events
JSW Dulux opens special window to dematerialise physical shares
Apr 10, 2026
JSW Dulux Limited has notified the stock exchanges that it has published newspaper advertisements announcing a special window for the transfer and dematerialisation of physical share certificates. The notice, carried in an English and a Bengali da...
JSW Dulux Releases Investor Presentation Ahead of March 16 Call
Mar 16, 2026
JSW Dulux Limited has released an investor presentation and scheduled an investor call on 16 March 2026 to engage with shareholders and market participants. The presentation, made available on the company’s website, signals an effort to enha...
Akzo Nobel India Renames Itself JSW Dulux After Regulatory Nod
Mar 11, 2026
JSW Dulux Limited has received approval from India’s Ministry of Corporate Affairs to change its corporate name from Akzo Nobel India Limited to JSW Dulux Limited, effective 11 March 2026. The company’s Memorandum and Articles of Assoc...
Akzo Nobel India Plans Investor Meet in Mumbai on March 16
Mar 11, 2026
Akzo Nobel India Limited has scheduled a group investor meeting with analysts and institutional investors on 16 March 2026 in Mumbai, organized by ICICI Securities, to engage with the financial community. The company has clarified that the meeting...
Akzo Nobel India Discloses Draft Tax Assessment Proposing Rs 111.63 Crore Additions
Mar 9, 2026
Akzo Nobel India Limited has disclosed that the Income Tax Department’s Assessing Officer has issued a draft assessment order for assessment year 2023-24, proposing additions of Rs 111.63 crore to the company’s taxable income under cor...
Akzo Nobel India Shares Investor Call Recording and Plans Transcript Release
Feb 3, 2026
Akzo Nobel India Limited has informed the stock exchanges that its senior management conducted a group investor conference call on 3 February 2026 to discuss the company’s financial results for the quarter and nine months ended 31 December 2...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.